Latest Industry Insights
Industry Insight
AI-Powered Platforms Are Making Complex Data Usable for Drug Discovery
In this interview, we explore how Sonrai is advancing reproducible science, enabling cross-disciplinary collaboration and shaping the future of AI-powered drug discovery.
Industry Insight
Circular RNA: The Next Frontier for RNA Therapeutics?
Discover how circular RNA and targeted delivery technologies are advancing RNA therapeutics for chronic diseases and vaccines.
Industry Insight
How Biotech Startups Are Redefining 3D Models and Sustainability in Drug Discovery
Explore how biotech start-ups are using 3D models and automation to reduce animal testing, cut waste and improve drug discovery outcomes.
Industry Insight
Can Patients Trust a Drug Designed By AI?
Patient trust is vital as AI transforms pharma and drug discovery. Discover how transparency and regulation are making innovation safer.
Industry Insight
How Crowdfunding Could Change the Cell and Gene Therapy Investor Landscape
Discover how crowdfunding could help biotech startups and cell and gene therapy developers overcome funding barriers by engaging patients, physicians and everyday investors.
Industry Insight
Improving the Accessibility of AAV Quantification in Gene Therapy Development
Learn how the Amperia platform improves AAV quantification accuracy and speed, making gene therapy development more accessible and consistent.
Industry Insight
Overcoming Toxicity Challenges in Gene Therapy
Explore the dosing challenges posed by current gene therapies and how circular RNA may unlock more potent and safer therapies.
Industry Insight
The Challenges of Conducting Rare Disease Clinical Trials
Explore the unique issues of rare disease trials and how “gene silencing” therapies could reshape the future for patients with H-ABC.
Industry Insight
Lipid-Free Cell Delivery System Wins ELRIG Drug Discovery 2025 Innovation Award
ELRIG Drug Discovery 2025 recognizes BubbleFect, a lipid-free cell delivery system that utilizes phase separation peptides for non-viral gene therapy delivery.
Industry Insight
$3.4 Billion Acquisition To Bring Life-Changing Therapies to More Rare Tumor Patients
Discover how one of the biggest biopharma acquisitions of 2025 aims to expand rare tumor therapies for hard-to-treat cancers like desmoid tumors.
Advertisement